ArticleAddiction science & clinical practice2013
Confidentiality protections versus collaborative care in the treatment of substance use disorders.
Article in Addiction science & clinical practice, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Outpatient follow-up and use of medications for opioid use disorder after residential treatment among Medicaid enrollees in 10 states.Drug and alcohol dependence · 2022Pooled it
- A learning health system model for addressing substance use: Denver Health Center for Addiction Medicine.Learning health systems · 2025Article
- Improving diagnosis-based quality measures: an application of machine learning to the prediction of substance use disorder among outpatients.BMJ open quality · 2025Article
- A scoping review of barriers and facilitators to the integration of substance use treatment services into US mainstream health care.Drug and alcohol dependence reports · 2023Article
- The Affordable Care Act: an opportunity for improving care for substance use disorders?Psychiatric services (Washington, D.C.) · 2015Review
- Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.Implementation research and practiceArticle
- Recommendations to Inform Substance Use Disorder Data Sharing Research: Scoping Review and Thematic Analysis.Journal of addiction medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Practitioners in federally-assisted substance use disorder (SUD) treatment programs are faced with increasingly complex decisions when addressing patient confidentiality issues. Recent policy changes, intended to make treatment more available and accessible, are having an impact on delivery of SUD treatment in the United States. The addition of electronic health records provides opportunity for more rapid and comprehensive communication between patients' primary and SUD care providers while promoting a collaborative care environment. This shift toward collaborative care is complicated by the special protections that SUD documentation receives in SUD treatment programs, which vary depending on what care is provided and the setting where the patient is treated. This article explores the special protections for substance abuse documentation, discrepancies in treatment documentation, ways to deal with these issues in clinical practice, and the need for more knowledge about how to harmonize treatment in the SUD and primary care systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.